Marginal Bone Loss Around the Implant of Screw-retained Implant Restorations in the Esthetic Zone Using PEEK With Composite Veneering Versus Monolithic Zirconia Restorations Using a Fully Digital Workflow: A Randomized Controlled Clinical Trial
| Registry | NCT07886008, acronym RCT |
|---|---|
| Status | Completed |
| Phase | Not applicable |
| Study type | Interventional; randomized, parallel, masking: double, other |
| Enrollment | 48 (Actual) |
| Sponsor | Cairo University (Other) |
| Conditions | Partial Edentulism Class IV |
| Interventions | PEEK (Polyetheretherketone) screw-retained implant restoration veneered with composite, Monolithic zirconia screw-retained implant restoration (Procedure) |
| Dates | start 2025-04-10, primary completion 2026-08-10, completion 2026-08-30, first posted 2026-10-21, last updated 2026-10-21 |
| Locations | 1 site in Egypt |
Related Papers Related Patents Related Grants Related Experts
All trials for Partial Edentulism Class IV All trials of PEEK (Polyetheretherketone) screw-retained implant restoration veneered with composite All trials of Monolithic zirconia screw-retained implant restoration
This study compares two different materials used for screw-retained dental implant restorations in the front of the upper jaw (the "esthetic zone"). The goal is to determine which material is better at preserving the bone level around the implant over time and how this will affect the survival rate of the restorations
Purpose of the Study
The primary purpose of this randomized controlled clinical trial is to compare two specific materials used for screw-retained dental implant restorations in the "esthetic zone" (the front of the upper jaw) to see which one better preserves the surrounding bone.
Core Research Objective
The study aims to evaluate whether PEEK (Polyetheretherketone) veneered with composite is superior to monolithic zirconia in decreasing marginal bone loss around dental implants.
The Scientific Rationale
Researchers are investigating these materials for several key reasons:
* Stress Distribution:** PEEK has an elastic modulus (flexibility) similar to human bone. It is believed this may help avoid high-stress transfer at the bone-implant interface and reduce "stress shielding," which can lead to bone loss.
* Improving on Current Standards:** While monolithic zirconia is popular due to its high esthetic potential and biocompatibility, it is very rigid, and common failures include the chipping of veneering porcelain.
* Establishing Gold Standards:** The study seeks to determine a "gold standard" for screw-retained restorations that can maximize implant survival rates and enhance the quality of life for partially edentulous patients.
* Clinical Guidance:** The findings are intended to provide clinicians with specific precautions and recommendations for implant planning in the esthetic zone to enhance overall treatment success.
Primary and Secondary Outcomes
To fulfill this purpose, the study measures two main factors:
1. Primary Outcome:** The amount of **marginal bone loss** (measured in millimeters) using digital X-rays at 6 and 12 months.
2. Secondary Outcome:The **survival rate** of the different types of restorations over the one-year follow-up period.
| Arm | Type | Interventions | Description |
|---|---|---|---|
| Marginal bone loss around Monolithic Zirconia screw-retained implant restoration | Active comparator | Procedure: Monolithic zirconia screw-retained implant restoration | The "gold standard" or comparator group (Control Group) consists of Monolithic Zirconia screw-retained restorations. The specific intervention for this group includes the following steps: Surgical Phase: Each participant receives two dental implants installed in the esthetic areas of the maxillary arch. Surgical Guidance: The implants are prosthetically driven and installed with the help of digitally constructed surgical guides. Provisional Phase: Temporary (provisional) restorations are loaded immediately after implant insertion and worn during the healing phase. Final Restoration: After three months of healing, the final fixed partial denture-made of monolithic zirconia-is inserted. Workflow: The entire process follows a fully digital workflow. Maintenance: Patients receive regular maintenance instructions and are recalled for follow-up assessments |
| Marginal bone loss around PEEK screw-retained implant restoration veneered with composite | Experimental | Procedure: PEEK (Polyetheretherketone) screw-retained implant restoration veneered with composite | In this clinical trial, the intervention group receives **PEEK (Polyetheretherketone) screw-retained restorations veneered with composite** The specific steps and components for this group include: * Implant Placement:** Each participant receives two dental implants in the upper front (maxillary esthetic) zone. * Surgical Guidance:** The implants are placed using a prosthetically driven approach with the aid of digitally constructed surgical guides. * Provisional Loading:** Temporary restorations are loaded immediately after the implants are inserted and worn throughout the healing phase. * Final Restoration:** After three months of healing, the final fixed partial denture-made of PEEK and veneered with "Visio-lign" composite-is inserted. * Digital Workflow:** The design and fabrication of the restoration follow a fully digital CAD/CAM workflow. * Monitoring:** The health of the bone around the implants is measured using digital X-rays at 6 and 12 months |
Sex: All, ages: 20 Years to 50 Years
Inclusion Criteria: * Missing Teeth: Patients must be partially edentulous, specifically missing teeth in the upper (maxillary) aesthetic zone * Age: between the ages of 20 and 50 years. * Systemic Health: Individuals must be free from any systemic diseases * Jaw Relationship: Participants must have an Angle's Class I skeletal relationship. * Facial Structure: Patients must demonstrate normal facial symmetry Exclusion Criteria: * Jaw Joint Issues: Patients suffering from Temporomandibular Disorder (TMD) problems. * Smoking Status: Heavy smokers are excluded from the study. * Bone and Tissue Health: Patients with existing bone loss in the anterior (front) area, flabby tissues, or a sharp residual ridge. * Neuromuscular Disorders: Any patient with a neuromuscular disorder is ineligible
| Facility | City | Country | Status |
|---|---|---|---|
| Cairo University | Giza, Giza Governorate | Egypt |